MVGBX
Price
$17.03
Change
+$0.04 (+0.24%)
Updated
Apr 2 closing price
Net Assets
264.63M
RWIBX
Price
$62.90
Change
+$0.23 (+0.37%)
Updated
Apr 2 closing price
Net Assets
122.78B
Ad is loading...

MVGBX vs RWIBX

Header iconMVGBX vs RWIBX Comparison
Open Charts MVGBX vs RWIBXBanner chart's image
MFS Low Volatility Global Equity B
Price$17.03
Change+$0.04 (+0.24%)
VolumeN/A
Net Assets264.63M
American Funds Capital World Gr&Inc R2
Price$62.90
Change+$0.23 (+0.37%)
VolumeN/A
Net Assets122.78B
MVGBX vs RWIBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MVGBX vs. RWIBX commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MVGBX is a StrongBuy and RWIBX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RWIBX has more cash in the bank: 123B vs. MVGBX (265M). RWIBX pays higher dividends than MVGBX: RWIBX (0.92) vs MVGBX (0.62). MVGBX was incepted earlier than RWIBX: MVGBX (11 years) vs RWIBX (23 years). MVGBX (1.82) is less costly to investors than RWIBX (1.51). MVGBX is a more actively managed with annual turnover of: 32.00 vs. RWIBX (27.00). RWIBX has a lower initial minimum investment than MVGBX: RWIBX (250) vs MVGBX (1000). MVGBX annual gain was more profitable for investors over the last year : 4.50 vs. RWIBX (0.05). RWIBX return over 5 years is better than : 64.01 vs. MVGBX (52.13).
MVGBXRWIBXMVGBX / RWIBX
Total Expense Ratio1.761.51117%
Annual Report Gross Expense Ratio1.821.51121%
Fund Existence11 years23 years-
Gain YTD3.9050.679575%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets265M123B0%
Annual Yield % from dividends0.620.9267%
Returns for 1 year4.500.059,906%
Returns for 3 years10.8610.51103%
Returns for 5 years52.1364.0181%
Returns for 10 years57.1438.23149%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
APVO1.380.38
+38.26%
Aptevo Therapeutics Inc
LCTX0.440.03
+6.37%
Lineage Cell Therapeutics
BIO245.525.52
+2.30%
Bio-Rad Laboratories IncClass A
HLLY2.57N/A
N/A
Holley
TR31.29-0.28
-0.89%
Tootsie Roll Industries Inc